Natco Pharma Ltd.

Natco Pharma is planning to raise fund through issue of shares or Convertible Securities of any nature in the form of Private Placement, Qualified Institutional Placement (QIP) to Foreign Institutional Investors (FIIs), Qualified Institutional Buyers or any other investors etc. In this regard, the meeting of the board of directors of the company will be held on May 22, 2015.

The company will also consider increase of equity investment percentage in the Company to 49% to FIIs / Foreign Portfolio Investors (FPIs) etc. Further, the company will also consider Merger of Natco Organics, 100% subsidiary, into itself.

Natco Pharma was promoted as a private company to be in the business of research, developing, manufacturing and marketing of pharmaceutical substances and finished dosage forms for Indian and International markets.